Spermosens AB (XSAT:SPERM) ROE % Adjusted to Book Value : -138.96% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Spermosens AB ROE % Adjusted to Book Value?

Spermosens AB's ROE % for the quarter that ended in Sep. 2024 was -37.52%. Spermosens AB's PB Ratio for the quarter that ended in Sep. 2024 was 0.27. Spermosens AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -138.96%.

Spermosens AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Spermosens AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spermosens AB ROE % Adjusted to Book Value Chart

Spermosens AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-5.23

-32.32

-58.56

Spermosens AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial													-39.19	-13.85	-58.34	-85.78	-138.96

Competitive Comparison of Spermosens AB's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Spermosens AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spermosens AB's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spermosens AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Spermosens AB's ROE % Adjusted to Book Value falls into.

Spermosens AB ROE % Adjusted to Book Value Calculation

Spermosens AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-131.76%	/	2.25
	=	-58.56%

Spermosens AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-37.52%	/	0.27
	=	-138.96%

Spermosens AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Spermosens AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Spermosens AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spermosens AB (XSAT:SPERM) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

9R5:Germany

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.spermosens.com

Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.

Spermosens AB Headlines

No Headlines